outperform price
medicar advantag
although strong result alter manag
frame slower reason earn growth
face health insur fee return tail ramp
margin increment medicar advantag enrol
growth year plu tap upsid pull forward
invest improv benefit next year bid
minimum provid cushion flexibl
sure aid long-term growth boost price
target out-year forecast remain top pick
near-term catalyst beyond acceler share
repurchas market cap launch close tonight
includ potenti medicar execut order presid
trump next week intend counterpoint
medicare-for-al could promot medicar advantag
plu also look action hif relief
congress return fall
favor util trend adv
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
articl articl
time dissemin juli
analyst michael newshel primarili respons prepar research report attest follow view
opinion render research report reflect person view subject compani issuer part
research analyst compens directli relat specif recommend view research report
